Provided by Tiger Trade Technology Pte. Ltd.

BARD1 Life Sciences

1.035
0.000
Volume:- -
Turnover:228.32K
Market Cap:95.24M
PE:-5.17
High:1.035
Open:1.035
Low:1.035
Close:1.035
52wk High:1.035
52wk Low:1.035
Shares:92.02M
Float Shares:75.44M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.200
EPS(LYR):-0.144
ROE:-62.77%
ROA:-19.80%
PB:3.28
PE(LYR):-7.17

Loading ...

Company Profile

Company Name:
BARD1 Life Sciences
Exchange:
ASX
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
BARD1 Life Sciences Limited engages in the research and development of non-invasive diagnostic tests for early detection of cancer in Australia. It is developing BARD1 lung cancer test, a screening test for the early detection of lung cancer in high-risk asymptomatic individuals; and BARD1 ovarian cancer test to detect ovarian cancer in high-risk women with a family history of breast/ovarian cancer or carrying BRCA1/2 mutations. The company has a collaboration with the Institute for Respiratory Health to evaluate a potential BARD1 cancer vaccine for the prevention and/or treatment of cancer in animal models. BARD1 Life Sciences Limited is based in South Perth, Australia.